The State of Drug Diversion Report in 2025 explores healthcare leaders’ perceptions of drug diversion monitoring programs. Consistent with prior years’ studies, almost all survey participants believe that drug diversion occurs in hospitals across the U.S., but that most incidents go unreported. Additionally, about two-thirds of participants say they are either “not confident” or only “somewhat confident” in their organization’s drug diversion program’s effectiveness.
Discover the insights you need to strengthen your drug diversion prevention efforts by downloading Wolters Kluwer's State of Drug Diversion Report. Packed with valuable data, this report gives healthcare professionals an in-depth understanding of the current landscape, challenges, and opportunities in diversion detection.
In this report, you will discover:
- How staffing trends are shifting, with more organizations dedicating three or more full-time employees to diversion prevention.
- The critical role of underrepresented departments like anesthesiology and human resources in tackling high-risk areas and managing incidents.
- The growing importance of advanced technologies like AI and machine learning (ML) tools in identifying drug diversion with speed and precision.
- Actionable insights on addressing cultural barriers, such as the "culture of silence," to foster accountability and vigilance.
- Strategies to engage executive leadership by framing drug diversion prevention as a patient safety, compliance, and financial priority.
